Biotherapeutics Invest Information

Arcutis Biotherapeutics Announces Inducement Grants in Compliance with Nasdaq Rules Dec 3, 2023

Aeglea BioTherapeutics AGLE Receives Sell Rating Amid Market Dynamics Nov 13, 2023